Envista Holdings Corporation
A global dental products company that makes the implants, clear aligners, and imaging gear dentists and orthodontists use every day, with brands like Nobel Biocare, Ormco, Kerr, and Spark aligners sold in more than 130 countries. Born in 2019 as a spinoff of Danaher Corporation's dental business, its name combines Latin roots meaning "to be within" and "a view," a nod to looking ahead — and its logo's concentric circles are meant to suggest endless collaborative possibilities.
Granted 666.8K · Bought 30.0K
Granted 1.13M · Bought 20.0K · Sold 631.8K
Granted 96.0K · Bought 24.5K
Granted 60.1K
Granted 77.4K
Granted 92.2K · Bought 5.0K
Granted 71.0K
Granted 113.1K · Bought 5.0K · Sold 20.2K
Granted 17.9K
Granted 43.7K
Granted 43.7K
Granted 54.1K
Granted 45.8K
Granted 45.8K
Granted 42.3K · Bought 2.0K
Granted 29.3K · Bought 2.2K
Granted 44.7K
Granted 17.9K
Granted 114.9K · Bought 5.0K · Sold 62.4K
Granted 27.3K
Granted 161.9K · Bought 2.0K · Sold 109.9K
Granted 73.1K · Bought 5.0K · Sold 34.5K
Granted 33.9K
Granted 157.3K · Bought 1.0K · Sold 107.6K
Granted 14.8K
Granted 18.5K
Granted 4.0K
Granted 2.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Keel Paul AChief Executive Officer, Director · 11 transactions | — | 551.3K | 666.8K | 30.0K | — |
| Aghdaei AmirChief Executive Officer, Director · 68 transactions | — | 310.6Kas of Feb 2024 | 1.13M | 20.0K | 631.8K |
| Hammes Eric D.Chief Financial Officer · 7 transactions | — | 99.9K | 96.0K | 24.5K | — |
| Huennekens R ScottDirector · 6 transactions | — | 82.1K | 60.1K | — | — |
| Hulit Barbara B.Director · 8 transactions | — | 79.8Kas of Jun 2025 | 77.4K | — | — |
| Eriksson PatrikSenior Vice President · 15 transactions | — | 79.7Kas of Sep 2023 | 92.2K | 5.0K | — |
| Geiselhoeringer HansSENIOR VICE PRESIDENT · 2 transactions | — | 74.4Kas of Feb 2020 | 71.0K | — | — |
| Nance Mark EGeneral Counsel · 43 transactions | — | 68.6K | 113.1K | 5.0K | 20.2K |
| Nilsson StefanPresident, Nobel Biocare · 5 transactions | — | 61.6K | 17.9K | — | — |
| Carruthers WendyDirector · 7 transactions | — | 59.9K | 43.7K | — | — |
| Tsingos Christine ADirector · 6 transactions | — | 59.9K | 43.7K | — | — |
| Kaabi Faez CChief Accounting Officer · 6 transactions | — | 58.6K | 54.1K | — | — |
| Gallahue KieranDirector · 7 transactions | — | 54.0K | 45.8K | — | — |
| Raskas DanielDirector · 7 transactions | — | 54.0K | 45.8K | — | — |
| Keller StephenPrincipal Financial Officer · 4 transactions | — | 53.8Kas of Jun 2024 | 42.3K | 2.0K | — |
| Conley EricSVP, Orthodontics · 10 transactions | — | 53.2Kas of May 2024 | 29.3K | 2.2K | — |
| Jain VivekDirector · 7 transactions | — | 52.9K | 44.7K | — | — |
| Acurio VeronicaPresident, Orthodontics · 5 transactions | — | 48.8K | 17.9K | — | — |
| Bludworth Curt WChief Human Resources Officer · 20 transactions | — | 46.8Kas of Mar 2022 | 114.9K | 5.0K | 62.4K |
| Befidi RobertPresident, Diagnostics · 8 transactions | — | 45.8K | 27.3K | — | — |
| Yu Howard HChief Financial Officer · 44 transactions | — | 43.9Kas of Sep 2023 | 161.9K | 2.0K | 109.9K |
| Kappler JeffreySenior Vice President · 28 transactions | — | 37.3Kas of Nov 2021 | 73.1K | 5.0K | 34.5K |
| Kyrillos Jean-ClaudeSenior Vice President · 7 transactions | — | 27.8Kas of Feb 2023 | 33.9K | — | — |
| Reis MischaSVP, Strategy & Bus. Dev. · 47 transactions | — | 27.3K | 157.3K | 1.0K | 107.6K |
| Moore Kari LynVP & Chief Acct. Officer · 7 transactions | — | 25.3Kas of Feb 2022 | 14.8K | — | — |
| Pierce James AndrewDirector · 2 transactions | — | 18.5K | 18.5K | — | — |
| Sheppard Teresa GayleDirector · 1 transaction | — | 10.5Kas of May 2021 | 4.0K | — | — |
| Daniel William KDirector · 1 transaction | — | 2.0Kas of Dec 2019 | 2.0K | — | — |
| Danaher Corp /De/10% owner · 1 transaction | — | 0as of Dec 2019 | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -864.6K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.